Continuing my thoughts.... If all we do is show
Post# of 148190
If all we do is show that we reduce the serious adverse events by 64%, that is miles ahead of what is out there currently.
But, what if we show that 100% of patients improve on Leronlimab? Think about that for a minute. And then think about it again.